Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2) Post date November 16, 2022 ← Long-term effect of overnight orthokeratology on axial length elongation in childhood myopia: a 5-year follow-up study → Decreasing Peripheral Hyperopia With Distance-centre Relatively-plus Powered Periphery Contact Lenses Reduced The Rate Of Progress Of Myopia: A 5 Year Vision Crc Study
